CAPITAL MARKET OPERATIONS

Lexelians Avocats lawyers have recognized expertise in capital markets. The team is made up of Laurent Beauvoit, Jonathan Santoro and Romain Guez. We advise listed companies and investment banks on the following transactions:

  • Initial public offerings (Euronext, Growth, Access)
  • Securities offerings through public offerings and private placements: capital increases, issues of structured products (e.g. convertible bonds, bonds convertible into new or existing shares, bond redeemable in cash and shares), equity line, 
  • Debt restructuring
  • Investment in listed companies : threshold crossing and declarations of intent, control issues, other reporting obligations, prevention of market abuse;
  • Mergers, spin-off, contributions
  • Friendly or unsolicited tender offers (purchase, exchange, squeeze-out), public shares buy-back offers, delisting, takeover strategies (concerted action), anti-tender offer defense; 
  • Block trades, etc.
  • Governance: governance charters, best practices, directors' responsibilities.

For the fourth year running, Lexelians Avocats has been ranked as one of the "must-see" firms for small-cap equity and convertible capital markets transactions in the November 2023 ranking published by Décideurs - Leaders League magazine.

Laurent Beauvoit and his team have been involved in over two hundred financial operations, including IPOs (EDF, Horizontal Software, Predilife, Pherecydes Pharma, AMA, Toosla...), capital increases (Société Générale, France Telecom, Veolia Environnement, Rhodia, Eurobio Scientific ...), complex securities issues (convertibles, bond redeemable in cash and shares, bonds convertible into new or existing shares, bonds convertible into shares with attached shares warrants ... by Business Objects, Altran, Publicis, Eurobio Scientific ...), tender offers/exchange public offers/ public shares buy-back offers (Grand Marnier, Business Objects, Infogrames, Aurea, Horizontal Software, Hiolle Industrie ...) and bond issues (Aurea, Infogrames, Rhodia, CMA-CGM ...).

Our latest operations

Initial public offerings, listings

toosla

Toosla

IPO on Euronext Growth Paris ( €6.2M )

December 2021
Deal counsel

AMA Corporation

AMA Corporation

IPO on Euronext Growth
( 36M € )

June 2021
French board of the issuer

beaconsmind

Beaconsmind

IPO on Euronext Access+ Paris ( €2.5M )

February 2021
Deal Counsel

Pherecydes Pharma

Pherecydes Pharma

IPO on Euronext Growth
( 8M € )

February 2021
Deal Counsel

Pherecydes Pharma

Entech

IPO on Euronext Growth Paris ( €25M )

September 2021
Counsel of shareholder funds

Media Maker

Media Maker

Private placement listing on Euronext Access Paris ( € 2.5M )

July 2019
Corporate and stock market consulting

Predilife

Predilife

IPO on Euronext Growth
( 2.6M € )

December 2018
Deal counsel

Parx Plastics

Parx Plastics

Private placement listing on Euronext Access Paris

May 2018
Corporate and stock market advisory

Medialab

Medialab

Private placement listing on Euronext Access Paris

March 2018
Corporate and stock market advisory

Gour Medical

Gour Medical

Private placement listing on Euronext Access Paris

December 2016
Corporate and stock market advisory services

Horizontal Software

Horizontal Software

IPO on Euronext Growth Paris ( € 6M )

December 2016
Deal counsel

Orclass

Orclass

Private placement listing on Euronext Access Paris

November 2014
Corporate board

Groupe Concourmania

Groupe Concourmania

IPO on Euronext Growth Paris ( € 9.2M )

May 2011
Deal counsel

Capital increase (private placements and public offerings)

toosla

ST Dupont

Capital increase with preferential subscription rights ( €25M )

February 2024
Corporate and securities law counsel of the Company

toosla

AMA

Issuance of shares by public offering ( € 8M )

June 2023
Counsel of the company

theraclion

Theraclion

Issuance of ABSA by private placement and public offering ( €12.7M )

June 2023
Counsel of the company

toosla

Toosla

Issuance of shares by private placement and public offering
( 3,6M € )

March 2023
Board of Directors

Abivax

Abivax

Private placement share issue
( 180M € )

February 2023
Corporate Investors Council

Metavisio Thomson

Metavisio Thomson

Issuance of shares by private placement and public offering
( 3,6M € )

November 2022
Board of Directors

Abivax

Abivax

Private placement share issue ( €49M )

September 2022
Corporate counsel of investors

Visiomed

Visiomed

Private placement share issue
( 1,7M € )

May 2022
Corporate and stock market advisor

theraclion

Theraclion

Private placement share issue
( 6,5M € )

March 2022
Corporate and securities law counsel of the Company

Visiomed

Visiomed

Private placement share issue
( 3,2M € )

March 2022
Corporate and securities law counsel of the Company

Visiomed

Visiomed

Private placement share issue ( €2M )

September 2021
Corporate and stock market advisory services

Visiomed

Visiomed

Private placement share issue ( €2M )

January 2021
Corporate and stock market advisory services

Predilife

Predilife

Public offering of shares
( 2M € )

December 2020
Corporate and stock market advice to the issuer

Horizontal Software

Horizontal Software

Issue reserved for named persons
( 4,5M € )

April 2020
Corporate and stock market advisory services

Hybrigenics Pharma

Hybrigenics Pharma

Equity line (€4M)

November 2019
Corporate and stock market advisory services

Gour Medical

Gour Medical

Private placement

September 2019
Corporate and stock market consulting

theraclion

Theraclion

Private placement of shares and OCAs
( 4.8M € )

March 2019
Corporate and stock market consulting

Eurobio Scientific

Eurobio Scientific

Private placement share issue ( €3M )

March 2019
Corporate and stock market consulting

Eduniversal

Eduniversal

Private placement

March 2019
Corporate and stock market consulting

Horizontal Software

Horizontal Software

Private placement share issue ( €3M )

March 2019
Corporate and stock market consulting

Gour Medical

Gour Medical

Private placement

February 2019
Corporate and stock market consulting

Horizontal Software

Horizontal Software

Private placement share issue ( €1.3M )

February 2018
Corporate and stock market advisory

theraclion

Theraclion

Private placement share issue
( 4,2M € )

October 2017
Corporate and stock market advisory

Eurobio Scientific

Eurobio Scientific

Public offering of shares
( 28,9M € )

February 2017
Corporate and stock market advisory

theraclion

Theraclion

Capital increase with preferential subscription rights ( € 10M )

August 2016
Corporate and stock market advisory

theraclion

Theraclion

Private placement share issue ( €1.8M )

May 2016
Corporate and stock market advisory services

Eurobio Scientific

Eurobio Scientific

Issuance of shares reserved for a category of persons (TEPA law)

November 2015
Corporate and stock market consulting

theraclion

Theraclion

Private placement share issue ( €4M )

June 2015
Corporate and stock market consulting

Eurobio Scientific

Eurobio Scientific

Issuance of shares reserved for a category of persons (TEPA law)

May 2015
Corporate and stock market advisory services

Eurobio Scientific

Eurobio Scientific

Issuance of shares reserved for a category of persons (TEPA law)

May 2014
Corporate and stock market advisory services

Issues of composite securities, equity lines, bonds

Plant Advanced Technologies

Plant Advanced Technologies

ORA issue ( 1M€ )

February 2024
Issuer's board

Hybrigenics

Hybrigenics

OCA issue ( €1.5M )

October 2023
Issuer's Board

Poxel

Versity

Issue of shares, warrants and convertible bonds ( €19.6M )

May 2023
Board of Directors

Abionyx

Abionyx

OCA issue ( €12M )

May 2023
Counsel of the investor

Poxel

Poxel

Issue of BEORA
( 20M € )

March 2023
Investor tip

Cibox

Cibox

Equity line BEORA
( 2M € )

December 2022
Investor tip

Poxel

Poxel

OCA issue ( €6M )

August 2022
Investor advice

Energisme

Energisme

Equity line OCABSA
( 12M € )

July 2022
Issuer's Board

Hopium

Hopium

Equity Line ( € 50M )

June 2022
Investor advice

Energisme

Energisme

Equity line BEORA
( 10M € )

January 2022
Investor tip

Cibox

Cibox Inter@ctive

Equity line BEORA
( 1,5M € )

July 2021
Investor advice

Boostheat

Boostheat

Issue of BEORA
( 10M € )

May 2021
Issuer's Board

Auplata Mining Group

Auplata Mining Group

Private placement issue of ORABSA ( €50M )

May 2021
Deal Counsel

Hybrigenics

Hybrigenics

NRS private placement issue ( €50M )

March 2021
Deal Counsel

Visiomed Group

Visiomed Group

OCABSA private placement issue
( 180M € )

February 2021
Issuer's Board

Cerinnov Group

Cerinnov Group

Equity line ( € 2M )

December 2020
Investor's Council

Visiomed Group

Visiomed Group

Equity line ( € 20M )

February 2021
Corporate and stock market advice to the issuer

DBT

DBT

BSA issue ( €20M )

November 2020
Corporate and stock market advice to the issuer

Theranexus

Theranexus

Equity line ( € 4.2M )

July 2020
Corporate and stock market advice to the investor

Santhera

Santhera

Equity Line ( CHF 12M )

April 2020
Corporate and stock market advice for investors

vergnet

Vergnet

Equity line ( 1M € )

February 2020
Corporate and stock market advice for investors

DMS Group

DMS Group

ORNANE issue
( 4M € )

December 2019
Investor advice

Novacyt Group

Novacyt Group

Equity line ( € 5M )

April 2019
Investor advice

Theraclion

Theraclion

Private placement of shares and OCAs
( 4.8M € )

March 2019
Corporate and stock market consulting

GECI International

GECI International

ORNANE issue
( 4M € )

February 2019
Corporate and stock market consulting

Horizontal Software

Horizontal Software

Issue of OCEANE bonds with warrants ( € 2M )

July 2018
Corporate and stock market advisory

Aurea

Aurea

Bond issue ( € 5M )

June 2018
Corporate and stock market advisory

Theraclion

Theraclion

Equity line ( 3.6M € )

July 2018
Corporate and stock market advisory

vergnet

Vergnet Group

Equity line ( 2 tranches of 2M € )

May 2018
Corporate and stock market advisory

Sepimo

Sepimo

OCA issue ( € 5M )

February 2018
Corporate counsel of the company.

GECI International

GECI International

ORNANE issue
( 9M € )

July 2017
Corporate and stock market advisory

SCBSM

SCBSM

ORNANE issue
( 20M € )

May 2017
Corporate and stock market advisory

Theraclion

Theraclion

Equity line ( 3M € )

March 2015
Corporate and stock market advisory services

Eurobio Scientific

Eurobio Scientific

Issue of OCABSA
( 10M € )

June 2014
Corporate and stock market consulting

Aurea

Aurea

Bond issue ( €13.6M )

June 2013
Corporate and stock market consulting

Offers (tender offers, exchange offers, public buy-in offers and squeeze-out)

Groupe Hiolle Industries

Groupe Hiolle Industries

Takeover bid by Hiolle Développement and squeeze-out ( €5.45M )

July 2022
Corporate and stock market consulting

Horizontal Software

Horizontal Software

Takeover bid by Extens and squeeze-out

December 2020.
Corporate and stock market consulting

Aurea

Aurea

Public share buyback offer ( €15M )

October 2019
Deal counsel

Grand Marnier

Grand Marnier

Takeover bid initiated by Campari
( 680M € )

May 2016
Grand Marnier Stock Exchange Council

Mergers, spin-off, contributions, universal transfer of assets and liabilities

Hybrigenics

The Azur Selection

Acquisition of 100% of the capital of HOTELS DU GROUPE BOUCAU

February 2024
Purchaser's advice

Hybrigenics

Hybrigenics

Hybrigenics acquires majority stake in Inoviem

May 2021
Hybrigenics Board

Artéa Groupe

Artéa Groupe

Sale of a block of off-market shares
( 5.4M € )

February 2020
Deal counsel

Horizontal Software

Horizontal Software

Universal transfer of assets and liabilities of Tehems, LPDR, Formaeve and Equitime

June 2019
Group Corporate Council

Eurobio Scientific

Eurobio Scientific

Contribution in kind for the acquisition of Pathway Diagnostics
( 1M € )

June 2019
Corporate and stock market advisory services

Eurobio Scientific

Eurobio Scientific

Universal transfer of Eurobio's assets and liabilities

December 2018
Group Corporate Council

Horizontal Software

Horizontal Software

Contribution in kind in connection with the acquisition of Formaeva

December 2017
Corporate and stock market advisory

Eurobio Scientific

Eurobio Scientific

Universal transfer of assets and liabilities of Eurobio and Ingen

December 2017
Group Corporate Council

Eurobio Scientific

Eurobio Scientific

Contribution in kind for the acquisition of Capforce Plus ( €18.8M )

March 2017
Corporate and stock market advisory

Eurobio Scientific

Eurobio Scientific

Universal transfer of assets and liabilities of Ingen Biosciences and Ingen

December 2013
Group Corporate Council

Eurobio Scientific

Eurobio Scientific

Contribution in kind for the acquisition of Ingen Biosciences
( 10M € )

December 2012
Corporate and stock market advisory services

Realization & referencing Simplébo

Connection